Is CBD Legal in Paraguay?
May 29, 2026
CBD is legal as a prescription medicine in Paraguay under Ley 6007/17 and Decreto 9303/18, regulated by DINAVISA. See dispensing and import rules.
CBD is legal as a prescription medicine in Paraguay under Ley 6007/17 and Decreto 9303/18, regulated by DINAVISA. See dispensing and import rules.
CBD is legal in Paraguay for medical and pharmaceutical use under the framework established by Ley 6007/17 and its implementing decrees. DINAVISA (Direccion Nacional de Vigilancia Sanitaria) registers cannabidiol products as controlled medicines requiring prescription. The first domestic CBD medicines were approved in 2019 following the publication of Decreto 9303/18 regulating cannabis-based pharmaceuticals.
Cosmetic and food-grade CBD products are not separately authorized; products imported through Aduanas are screened for medicinal registration. Pharmacies dispense CBD oils for indications including refractory epilepsy, multiple sclerosis spasticity, and chemotherapy-induced nausea. The MSPBS maintains a patient registry. Prices for prescription CBD remain high relative to median wages, and informal imports of US-sourced isolates persist despite the formal channel.
This overview is not legal or medical advice. Patients should consult their physician and a licensed Paraguayan pharmacist; product registration status and prescription rules evolve with each DINAVISA cycle.
Legal
Direccion Nacional de Vigilancia Sanitaria (DINAVISA); Ministerio de Salud Publica y Bienestar Social (MSPBS)
Pharmaceutical CBD products typically <0.5% THC; medicinal extracts can exceed
Ley 6007/17; Decreto 9303/18 reglamentando el uso medicinal del cannabis
CBD pharmaceuticals may be imported by licensed wholesalers registered with DINAVISA. Paraguay has also licensed domestic producers to export CBD extracts to the EU and Latin American markets under medicinal-cannabis frameworks. Personal import requires a Paraguayan prescription.
